|Bid||1.1800 x 1300|
|Ask||1.2000 x 1000|
|Day's Range||1.0600 - 1.2000|
|52 Week Range||0.4400 - 1.8500|
|Beta (5Y Monthly)||2.40|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.25|
\\- Continued Advancement of XCART™ Platform Towards an IND Filing and Phase 1 Study\\- Leveraging Partnerships With Leading Global Academic Institutions, Including Scripps ResearchFRAMINGHAM, MA / ACCESSWIRE / November 13, 2020 / Xenetic Biosciences, Inc.
\\- Live video webcast with CEO, Jeffrey Eisenberg, on Tuesday, November 12th at 8:00 AM EST -FRAMINGHAM, MA / ACCESSWIRE / November 5, 2020 / Xenetic Biosciences, Inc.
Live video webcast with CEO, Jeffrey Eisenberg, on Wednesday, September 16th at 12:00 PM EDTFRAMINGHAM, MA / ACCESSWIRE / September 9, 2020 / Xenetic Biosciences, Inc.